Kemadrin

Procyclidine Hydrochloride, the active ingredient in Kemadrin, is an anticholinergic (muscarinic antagonist) presented as an oral tablet for oral use. It is employed to manage Parkinson's disease and drug‑induced extrapyramidal symptoms in adult patients.

GNH USA supplies Kemadrin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kemadrin (procyclidine) is used within the anticholinergic class to address movement disorders and related conditions.

- Parkinson's disease: improves motor control and reduces rigidity and tremor. - Drug‑induced extrapyramidal symptoms: alleviates drug‑induced rigidity, tremor, and dystonia. - Akathisia: lessens inner restlessness and the urge to move.

Procyclidine may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dry mouth: reduced salivation leading to discomfort. - Constipation: slowed gastrointestinal motility. - Blurred vision: difficulty focusing due to pupil dilation. - Dizziness: sensation of light‑headedness or imbalance. - Nausea: mild stomach upset. - Urinary retention: difficulty emptying the bladder.

Serious or Rare Side Effects: - Confusion or delirium: altered mental status, especially in the elderly. - Hallucinations: visual or auditory disturbances. - Severe tachycardia: rapid heart rate requiring medical attention. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Neuroleptic malignant syndrome: rare but life‑threatening condition with fever and muscle rigidity.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for safety concerns.

- Renal or hepatic impairment: adjust dose or monitor closely. - Anticholinergic burden: assess concurrent anticholinergic medications. - Glaucoma: use with caution due to potential intra‑ocular pressure increase. - Urinary retention or prostate enlargement: monitor urinary function. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Procyclidine can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Other anticholinergic agents: additive anticholinergic effects may increase toxicity. - Monoamine oxidase inhibitors (MAOIs): risk of exaggerated central nervous system effects. - QT‑prolonging drugs: potential for cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines): may enhance sedation. - Antihistamines with anticholinergic properties: increase risk of dry mouth, constipation, and blurred vision.